Sparoxomycin A2
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Category | Antibiotics |
Catalog number | BBF-02923 |
CAS | 174390-02-4 |
Molecular Weight | 377.44 |
Molecular Formula | C13H19N3O6S2 |
Online Inquiry
Description
It is produced by the strain of Str. sparsogenes SN 2325. It is a novel mammalian cell proliferation effector that converts the transformed phenotype of Rous sarcoma virus-infected NRK cells to a normal phenotype. It has weak antimicrobial activity (such as Escherichia coli) but has no effect on staphylococcus aureus, candida albicans and staphylococcus grayi.
Specification
Synonyms | 2-Propenamide, N-[(1S)-1-(hydroxymethyl)-2-[[S(R)]-[[[S(R)]-methylsulfinyl]methyl]sulfinyl]-ethyl]-3-(1,2,3,4-tetrahydro-6-methyl-2,4-dioxo-5-pyrimidinyl)-, (2E)- |
IUPAC Name | (E)-N-[(2S)-1-hydroxy-3-[(R)-[(R)-methylsulfinyl]methylsulfinyl]propan-2-yl]-3-(6-methyl-2,4-dioxo-1H-pyrimidin-5-yl)prop-2-enamide |
Canonical SMILES | CC1=C(C(=O)NC(=O)N1)C=CC(=O)NC(CO)CS(=O)CS(=O)C |
InChI | InChI=1S/C13H19N3O6S2/c1-8-10(12(19)16-13(20)14-8)3-4-11(18)15-9(5-17)6-24(22)7-23(2)21/h3-4,9,17H,5-7H2,1-2H3,(H,15,18)(H2,14,16,19,20)/b4-3+/t9-,23+,24+/m0/s1 |
InChI Key | ZIMCIWWBWLSQCN-VKTUOGNUSA-N |
Properties
Appearance | Colorless Powder |
Antibiotic Activity Spectrum | Gram-negative bacteria |
Melting Point | 170-174°C (dec.) |
Density | 1.559±0.06 g/cm3 (Predicted) |
Solubility | Soluble in Methanol |
Reference Reading
Recommended Products
BBF-03963 | Pristinamycin | Inquiry |
BBF-04736 | 3-Indolepropionic acid | Inquiry |
BBF-01829 | Deoxynojirimycin | Inquiry |
BBF-03816 | Milbemycin oxime | Inquiry |
BBF-04655 | Exatecan Mesylate | Inquiry |
BBF-03794 | Geneticin sulfate | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2